FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development | Orphanet Journal of Rare Diseases | Full Text

FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development | Orphanet Journal of Rare Diseases | Full Text

FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development

The Office of Orphan Products Development (OOPD) of the United States (U.S.) Food and Drug Administration (FDA) has awarded over 700 grants to conduct clinical trials of medicals products for rare diseases sin...

Authors:Kathleen L. Miller, Christine Mueller, Gumei Liu, Katherine I. Miller Needleman and Janet Maynard

Citation:Orphanet Journal of Rare Diseases 2020 15:234

Content type:Research

 

Published on: 3 September 2020

• ViewFull Text
 
• ViewPDF